Clinical Trial Update: Randomized Controlled Trial on the Use of Flammacerium in Necrotic Arterial Wounds of the Lower Limb Versus Standard Treatment [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating Flammacerium for ischemic/necrotic wounds of the lower limb has been terminated; the update provides no efficacy or safety r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Flammacerium

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Ischemic Wound of the Lower Limb, Necrotic Arterial Wounds | Phase 2 | Status: TERMINATED